Xcout Intel
Vandria competitors & alternatives
The 12 closest competitors and alternatives to Vandria among biotechnology companies — ranked by similarity to what Vandria actually does, not by market-cap band.
Subscribe to see Vandria’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Vandria
Vandria is a biotechnology research company founded in September 2021 and based at the Biopôle campus in Epalinges, Switzerland. The company specializes in discovering first-in-class small molecules targeting mitochondrial function to treat age-related diseases. It operates with a small team focused on novel metabolic pathways.
Vandria at a glance
Vandria is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series A, raised $30.7M in August 2024.
Vandria funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $30.7M | 3 named | |
| Series A | $20.6M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Vandria competitors
Ranked by semantic similarity — how close each company is to Vandria by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Cellvie AG is a biotechnology company based in Zurich, Switzerland, pioneering Therapeutic Mitochondria Transplantation to target cellular energy metabolism.
Life Sciences
Rejuveron Life Sciences AG is a biotechnology company headquartered in Schlieren, Switzerland, focused on developing innovative therapeutics and therapies for aging-related diseases and longevity.
Similar biotechnology company
Endurance Biotech, Inc. is a biopharmaceutical company that develops first-in-class oral small molecules designed to restore mitochondrial and lysosomal function for the treatment of neurodegenerative, metabolic, and age-related diseases. Its lead clinical program, T-168, targets Parkinson's disease by addressing interconnected cellular systems, reducing neuroinflammation, and enhancing autophagy.
Biotech
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Life Sciences
MitoRx Therapeutics is a platform biotechnology company headquartered in Oxford, England, developing novel mitochondrial-targeted therapeutics for life sciences.
Biotech
Abliva is a company headquartered in Lund, Sweden, focused on delivering mitochondrial health. It leverages in-house R&D capabilities to create a portfolio of projects with various mechanisms of action.
Biotech
ScandiBio Therapeutics is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, founded to develop pharmaceutical drugs targeting mitochondrial dysfunction.
Similar biotechnology company
Cambrian BioPharma, Inc. is a biotechnology company headquartered in New York, United States, focused on developing therapeutics to extend human healthspan.
Similar biotechnology company
Spring Discovery (also known as Spring Science) is a biotechnology research company founded in 2017 and based in San Carlos, California. The company focuses on therapeutics and drug discovery targeting age-related diseases.
Similar biotechnology company
Autonomy Bio Inc. is a biotechnology company focused on developing human aging therapeutics aimed at extending healthspan and mitigating age-related decline. The company targets individuals seeking to maintain health and independence as they age.
Biotech
Biophytis is a clinical-stage biotechnology company that develops transformative therapies to impact longevity, slow aging, and improve sustainable health. The company utilizes a research platform to discover new drug candidates, with its lead candidate BIO101 being evaluated for the treatment of conditions such as sarcopenia and obesity.
Similar biotechnology company
Ultimate Medicine AG is a Swiss preclinical biotechnology company headquartered in Zürich, focused on maximizing the healthspan of patients with Alzheimer's disease and other dementias by targeting novel toxic metabolites.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Vandria and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vandriaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →